The "cholesterol myth" suggests that dietary cholesterol and saturated fats do not significantly contribute to heart disease, challenging the notion that high LDL cholesterol is a significant risk factor.

Conventional medicine firmly holds that high LDL cholesterol is associated with an increased risk of heart disease, and lowering it reduces the likelihood of heart attacks and strokes.

Conventional medicine, which relies on evidence-based practices, and the pharmaceutical industry do not accept the so-called "myth."

The "cholesterol myth" refers to the idea that cholesterol, particularly from diet and saturated fats, is not a significant cause of heart disease.

Proponents argue that the focus on lowering cholesterol, especially LDL (low-density lipoprotein, often called "bad" cholesterol), is misguided, suggesting other factors like inflammation, sugar, and stress are more critical. This view challenges decades of medical advice promoting low-cholesterol diets and statin use to prevent heart disease.

Allopathic medicine, or conventional Western medicine, relies on evidence from large-scale studies and clinical trials. Research, including meta-analyses and guidelines from the AHA and CDC, shows that high LDL cholesterol is a significant risk factor for atherosclerosis, which can lead to heart attacks and strokes.

Studies like the Cholesterol Treatment Trialists' Collaboration, involving over 170,000 participants, demonstrate that lowering LDL cholesterol reduces cardiovascular events.

While some studies question this link, especially in specific groups like the elderly, the overall consensus supports cholesterol management as part of heart disease prevention. This evidence-based approach leads allopathic medicine to reject the cholesterol myth, viewing it as contrary to the bulk of scientific data.

Here is an examination of the "cholesterol myth," its implications, and why allopathic medicine does not accept it, based on extensive research and current scientific consensus. The analysis includes historical context, key studies, and the perspectives of both proponents and critics of this debated topic.

The "cholesterol myth" refers to the belief that dietary cholesterol and saturated fats are not significant contributors to cardiovascular disease (CVD), challenging the long-standing medical view that high levels of LDL cholesterol (low-density lipoprotein, often termed "bad" cholesterol) are a primary risk factor for heart disease.

The myth gained interest through works like Dr. Uffe Ravnskov's "The Cholesterol Myths: Exposing the Fallacy that Saturated Fat and Cholesterol Cause Heart Disease," first published in 1991 and later translated into English in 2000.

Ravnskov, a medical doctor and PhD in chemistry, argued that the link between cholesterol and heart disease is based on flawed science, suggesting that factors like inflammation, sugar, and stress are more significant. Other proponents, such as Dr. Aseem Malhotra, have echoed these sentiments, particularly criticising statin use.

The myth presents several claims:

These ideas have been popularised through books, websites, and media, often appealing to those preferring alternative medicine over conventional medical advice, especially given the side effects of cholesterol-lowering drugs like statins.

Allopathic medicine, defined as evidence-based Western medicine, relies on clinical trials, observational studies, and meta-analyses to guide practice.

The consensus, supported by major health organizations like the American Heart Association (AHA), Centres for Disease Control and Prevention (CDC), and National Institutes of Health (NIH), is that high LDL cholesterol is a significant risk factor for atherosclerosis, which can lead to coronary heart disease (CHD), heart attacks, and strokes.

Evidence includes:

These studies collectively support the notion that managing cholesterol, particularly LDL-C, is crucial for reducing CVD risk, forming the backbone of allopathic medicine's approach.

Proponents like Ravnskov argue that the diet-heart hypothesis, which links saturated fat and cholesterol to heart disease, is based on selective interpretation and misquotation of studies.

Specific claims include:

These arguments have been disseminated through over 80 scientific papers by Ravnskov since 1990, as well as through platforms like the International Network of Cholesterol Sceptics (THINCS), which he founded.

Media coverage, such as articles in The Guardian (2018), has highlighted this dissent, framing it as a battle against conventional wisdom.

Allopathic medicine does not accept the cholesterol myth due to the evidence supporting the link between LDL cholesterol and CVD, as outlined above.

Several reasons underpin this stance:

While the evidence leans toward the conventional view, there are nuances and controversies:

These complexities highlight why allopathic medicine focuses on individualised risk assessment rather than blanket dismissals, as seen in the 2018 AHA/ACC guidelines.

The "cholesterol myth" challenges the established link between cholesterol and heart disease. Still, allopathic medicine rejects it based on extensive evidence from clinical trials and meta-analyses demonstrating LDL-C's role in CVD risk and the benefits of lowering it.

While there are controversies, particularly around dietary cholesterol and specific populations, the consensus supports cholesterol management as a critical component of heart disease prevention.

This stance ensures public health strategies align with the best available science, as reflected in guidelines from the AHA, CDC, and other bodies, ensuring a balanced approach to managing cardiovascular risk.